Recent

% | $
Quotes you view appear here for quick access.

OCATA THERAPEUTICS, INC. Message Board

  • mike.morrie mike.morrie Apr 23, 2013 7:12 PM Flag

    Key phrase made by Robert Lanza MD today that most investors missed...

    “We are pleased to have now moved into the second-half of all our clinical trials for macular degeneration,” said Robert Lanza, M.D., chief scientific officer. “We are eagerly anticipating advancing toward the final cohort in all three trials.”

    Sentiment: Hold